Original Articles Vol. 3 No. 02 (2026): Bioscience Insights Published 2026-09-28

ASSOCIATION BETWEEN CD4 T-CELL COUNTS AND HEMATOLOGICAL ABNORMALITIES IN HIV-POSITIVE PATIENTS RECEIVING ANTIRETROVIRAL THERAPY

Authors

  • Aqsa Batool Department of Pathology, Shaukat Khanum Memorial Cancer Hospital and Research Center Lahore, Pakistan Pakistan Author
  • Ali Raza Nawab Airport Health Establishment, Border Health Services, Pakistan Pakistan Author
  • Waqas Ahmed Department of biochemistry, Hazara University, Pakistan Pakistan Author
  • Danial Hassan Adil nternal Medicine - DHQ Hospital Sheikhupura Pakistan Author
  • Eisha Tur Raazia Institute of Microbiology and Molecular Genetics (IMMG), University of the Punjab, Lahore, Pakistan Pakistan Author
  • Adnan Sami Government College University Lahore, Pakistan Pakistan Author
  • Maaz Ahmad NUMS, (Army Medical College) Pakistan Author
  • Hamna Shahid Atta-Ur-Rehman School of Applied Biosciences (ASAB), NUST Pakistan Author
  • Sarfraz Ahmad Health & Population Department, University of Health Sciences, Lahore Pakistan Author
  • Abdul Mueez Khan College of Pharmacy, University of Sargodha, Mandi Bahauddin, Punjab, Pakistan Pakistan Author
46 views 21 downloads

Abstract

Background: Hematological abnormalities are common complications in HIV infection. While cytopenias are common even on ART, the prognosis is better.

Objective: To assess relationship of CD4+ T-cell count and hematological parameters in HIV infected people on ART.

Methods: A cross-sectional study of 100 HIV-positive adults receiving treatment with ART was undertaken. Patients were stratified by CD4 counts: <200, 200–349, 350–499, and ≥500 cells/µL. ANOVA, chi-square and Pearson/Spearman correlation were used to check for hematological parameters.

Results: The overall prevalence of hematological abnormality was 65.0%. Primary anemia (60.0 %), leukopenia (12.0 %) and thrombocytopenia (6.0 %) were the main abnormalities. There was a significant step-wise increase in hemoglobin, RBC count, and HCT in the different ascending CD4 categories (p<0.0001). Anemia prevalence was 100.0% at CD4<200 versus 0.0% at CD4≥500 (Chi-Square=73.19, p<0.0001). Thrombocytopenia occurred exclusively in CD4<200 (24.0%, p=0.00025). Strong positive correlation was seen between CD4 and Hb (r=0.931), CD4 and HCT (r=0.902), and CD4 and RBC (r=0.721).

Conclusions: There is a strong association between severe CD4 immunosuppression and high prevalence of anemia and low platelet counts. Regular hematological monitoring is still critical for the assessment of the severity of the disease and decision making about treatment.

Keywords

  • HIV/AIDS, Antiretroviral Therapy, CD4 T-Cell Count, Anemia, Thrombocytopenia, Leukopenia, Hematology.

Views & Downloads Statistics (Last 12 Months)

Monthly performance and trends of article views and downloads

Views (12 months)46
Downloads (12 months)21
Article Views PDF Downloads